Home Contact Sitemap

PedAM

Pediatric Disease Annotations & Medicines




Disease schizophrenia
Phenotype C0011847|diabetes
Sentences 31
PubMedID- 20923916 The management of diabetes in schizophrenia is less well established than in the general population.
PubMedID- 25878665 This paper reviews the prevalence, etiology, and treatment of diabetes in schizophrenia and outlines office based interventions for physicians treating this vulnerable population.
PubMedID- 25937183 Conclusions: there is no evidence that type 2 diabetes patients with schizophrenia have worse diabetes control than those without a severe mental illness in general practices.
PubMedID- 20939648 A 75-g oral glucose tolerance test (ogtt) was performed in 22 mildly obese, diabetes-free, japanese patients with schizophrenia who received risperidone or olanzapine for at least 2 months.
PubMedID- 23775046 Background: the prevalence of diabetes in patients with schizophrenia is 2- to 3-fold higher than in the general population.
PubMedID- 26469976 Nasrallah et al reported a high proportion of under-diagnosis and under-treatment of hypertension, dyslipidemia and diabetes in schizophrenia [16].
PubMedID- 23840437 schizophrenia with diabetes performed worse than schizophrenia without diabetes in immediate memory (p<0.01) and total rbans scores (<0.05), and showed a trend for decreased attention (p = 0.052) and visuospatial/constructional capacity (p = 0.063).
PubMedID- 20304611 Conclusion: when treating schizophrenia patients with preexisting diabetes, psychiatrists need to monitor the occurrence of diabetes regularly regardless of antipsychotic class, strike a balance, and provide the most efficacious antipsychotic medication.
PubMedID- 21324239 The average annual incidence of diabetes in patients with schizophrenia was 1.84% from 2000 to 2005.
PubMedID- 22039372 Also, the risk of diabetes in schizophrenia is increased by use of atypical apds (lean and pajonk, 2003).
PubMedID- 21937796 Conclusion: the impairment of cognitive function in schizophrenia patients with diabetes is severer than schizophrenia patients, suggesting that the prevention and management of diabetes may improve cognitive outcome in schizophrenia patients.
PubMedID- 20923920 The increased prevalence of diabetes in patients with schizophrenia in an increasingly obesogenic society should be seen as a public health concern.
PubMedID- 26209325 Conclusion: elevated risk for type 2 diabetes in people with schizophrenia is not simply a consequence of antipsychotic medication; type 2 diabetes and schizophrenia share familial risk factors.
PubMedID- 20434886 A healthy lifestyle intervention for middle-aged and older schizophrenia patients with diabetes mellitus: a 6-month follow-up analysis.
PubMedID- 22472311 Indeed, there is evidence that there is a metabolic predisposition to diabetes in patients with schizophrenia that is exacerbated by obesity and thereby contributes to cardiovascular disease and other co-morbid illnesses.
PubMedID- 20923919 A community study in the usa examined how treatment of diabetes in patients with schizophrenia (n = 101) compared with that in diabetic patients with no mental illness (n = 99) (dixon et al., 2004).
PubMedID- 24688610 The only other publishedstudy comparing antihyperglycemic medication adherence between these two patientpopulations found that the prevalence of antihyperglycemic medication adherence wassignificantly greater (mpr=0.8-1.2) and antihyperglycemic medication nonadherence(mpr<0.8) was significantly lower in diabetes patients with schizophrenia thanwithout schizophrenia.12 our study did find arelationship between adherence rates for antipsychotic and antihyperglycemicmedication.
PubMedID- 25722989 Both these hormones play an important role in the onset of diabetes in patients with schizophrenia [17].
PubMedID- 21265491 Untreated hypertension, untreated dyslipidemia and untreated diabetes are strongly associated with schizophrenia (3.79 [1.63-8.81]), (3.79 [2.06-7.35]), (6.38 [1.725-23.59]), respectively.
PubMedID- 21424900 Predictors of quality of life in type 2 diabetes patients with schizophrenia, major mood disorder, and without mental illness.
PubMedID- 22028998 Similarly, a positive family history may increase the risk of developing diabetes in individuals with schizophrenia up to threefold.
PubMedID- 20467177 The insulin sparing effect of telmisartan in a case of type 2 diabetes mellitus associated with schizophrenia under treatment of risperidone.
PubMedID- 23369226 diabetes mellitus in patients with schizophrenia in west-bank, palestine.
PubMedID- 21414605 Methods: eleven known risk variants of type ii diabetes were genotyped in patients with schizophrenia in a sample of 410 danish patients, each matched with two healthy control subjects on sex, birth year, and month.
PubMedID- 20978096 Risk of acute complications of diabetes among people with schizophrenia in ontario, canada.
PubMedID- 22443212 The success of diet and lifestyle interventions to prevent or manage type ii diabetes in individuals with and without schizophrenia or schizoaffective disorders has been documented in the literature.
PubMedID- 23439746 Since the introduction of atypical antipsychotics nearly 20 years ago, there has been a 0.7% per year higher rate of diabetes type ii in patients with schizophrenia compared the general population.
PubMedID- 23941126 Methods: schizophrenia patients without (pre-)diabetes (n = 86) were compared with pre-diabetic (n = 10) and diabetic patients (n = 10).
PubMedID- 26555485 In schizophrenia with diabetes, males had significantly worse cognition than females in all cognitive domains.
PubMedID- 20923921 (2006) trialled a skills training intervention aimed at older schizophrenia patients with diabetes which achieved a significant reduction in weight gain at 6 months.
PubMedID- 25832526 Methods: relevant studies on schizophrenia with type 2 diabetes mellitus in china were searched through pubmed, medline, cbm, cnki and vip from 1997 to 2014.

Page: 1